Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 3
1964 5
1965 27
1966 70
1967 112
1968 120
1969 110
1970 147
1971 158
1972 175
1973 179
1974 175
1975 184
1976 174
1977 182
1978 189
1979 191
1980 212
1981 224
1982 318
1983 301
1984 337
1985 416
1986 364
1987 394
1988 413
1989 505
1990 504
1991 487
1992 503
1993 550
1994 512
1995 565
1996 549
1997 533
1998 587
1999 642
2000 730
2001 845
2002 970
2003 1025
2004 1120
2005 1301
2006 1543
2007 1672
2008 1808
2009 1980
2010 2423
2011 2568
2012 2638
2013 2688
2014 2772
2015 2844
2016 2770
2017 2778
2018 2826
2019 1619
2020 61
Text availability
Article attribute
Article type
Publication date

Search Results

45,774 results
Results by year
Filters applied: . Clear all
Page 1
Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma.
Mazur PK, Herner A, Mello SS, Wirth M, Hausmann S, Sánchez-Rivera FJ, Lofgren SM, Kuschma T, Hahn SA, Vangala D, Trajkovic-Arsic M, Gupta A, Heid I, Noël PB, Braren R, Erkan M, Kleeff J, Sipos B, Sayles LC, Heikenwalder M, Heßmann E, Ellenrieder V, Esposito I, Jacks T, Bradner JE, Khatri P, Sweet-Cordero EA, Attardi LD, Schmid RM, Schneider G, Sage J, Siveke JT. Mazur PK, et al. Nat Med. 2015 Oct;21(10):1163-71. doi: 10.1038/nm.3952. Epub 2015 Sep 21. Nat Med. 2015. PMID: 26390243 Free PMC article.
Molecular bases of the poor response of liver cancer to chemotherapy.
Marin JJG, Briz O, Herraez E, Lozano E, Asensio M, Di Giacomo S, Romero MR, Osorio-Padilla LM, Santos-Llamas AI, Serrano MA, Armengol C, Efferth T, Macias RIR. Marin JJG, et al. Clin Res Hepatol Gastroenterol. 2018 Jun;42(3):182-192. doi: 10.1016/j.clinre.2017.12.006. Epub 2018 Mar 12. Clin Res Hepatol Gastroenterol. 2018. PMID: 29544679 Review.
LANREOTIDE THERAPY IN CARCINOID SYNDROME: PROSPECTIVE ANALYSIS OF PATIENT-REPORTED SYMPTOMS IN PATIENTS RESPONSIVE TO PRIOR OCTREOTIDE THERAPY AND PATIENTS NAÏVE TO SOMATOSTATIN ANALOGUE THERAPY IN THE ELECT PHASE 3 STUDY.
Fisher GA Jr, Wolin EM, Liyanage N, Lowenthal SP, Mirakhur B, Pommier RF, Shaheen M, Vinik AI; ELECT Study Investigators. Fisher GA Jr, et al. Endocr Pract. 2018 Mar;24(3):243-255. doi: 10.4158/EP172000.OR. Endocr Pract. 2018. PMID: 29547049 Clinical Trial.
45,774 results
Jump to page
Feedback